Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to $4.0 million.

  • Ekso Bionics Holdings' Operating Expenses fell 1850.25% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.9 million, marking a year-over-year decrease of 916.29%. This contributed to the annual value of $20.0 million for FY2024, which is 1744.45% down from last year.
  • Ekso Bionics Holdings' Operating Expenses amounted to $4.0 million in Q3 2025, which was down 1850.25% from $4.8 million recorded in Q2 2025.
  • Ekso Bionics Holdings' 5-year Operating Expenses high stood at $7.0 million for Q4 2021, and its period low was $4.0 million during Q3 2025.
  • Moreover, its 5-year median value for Operating Expenses was $5.2 million (2024), whereas its average is $5.3 million.
  • In the last 5 years, Ekso Bionics Holdings' Operating Expenses soared by 5986.69% in 2021 and then tumbled by 2395.23% in 2024.
  • Ekso Bionics Holdings' Operating Expenses (Quarter) stood at $7.0 million in 2021, then dropped by 12.24% to $6.1 million in 2022, then fell by 4.84% to $5.8 million in 2023, then dropped by 15.02% to $4.9 million in 2024, then fell by 20.08% to $4.0 million in 2025.
  • Its last three reported values are $4.0 million in Q3 2025, $4.8 million for Q2 2025, and $5.2 million during Q1 2025.